» Articles » PMID: 37280085

Missense Variant Interaction Scanning Reveals a Critical Role of the FERM Domain for Tumor Suppressor Protein NF2 Conformation and Function

Abstract

NF2 (moesin-ezrin-radixin-like [MERLIN] tumor suppressor) is frequently inactivated in cancer, where its NF2 tumor suppressor functionality is tightly coupled to protein conformation. How NF2 conformation is regulated and how NF2 conformation influences tumor suppressor activity is a largely open question. Here, we systematically characterized three NF2 conformation-dependent protein interactions utilizing deep mutational scanning interaction perturbation analyses. We identified two regions in NF2 with clustered mutations which affected conformation-dependent protein interactions. NF2 variants in the F2-F3 subdomain and the α3H helix region substantially modulated NF2 conformation and homomerization. Mutations in the F2-F3 subdomain altered proliferation in three cell lines and matched patterns of disease mutations in NF2 related-schwannomatosis. This study highlights the power of systematic mutational interaction perturbation analysis to identify missense variants impacting NF2 conformation and provides insight into NF2 tumor suppressor function.

Citing Articles

Optimization of a deep mutational scanning workflow to improve quantification of mutation effects on protein-protein interactions.

Bendel A, Skendo K, Klein D, Shimada K, Kauneckaite-Griguole K, Diss G BMC Genomics. 2024; 25(1):630.

PMID: 38914936 PMC: 11194945. DOI: 10.1186/s12864-024-10524-7.


Mutational scanning pinpoints distinct binding sites of key ATGL regulators in lipolysis.

Kohlmayr J, Grabner G, Nusser A, Holl A, Manojlovic V, Halwachs B Nat Commun. 2024; 15(1):2516.

PMID: 38514628 PMC: 10958042. DOI: 10.1038/s41467-024-46937-x.

References
1.
Petrilli A, Fernandez-Valle C . Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2015; 35(5):537-48. PMC: 4615258. DOI: 10.1038/onc.2015.125. View

2.
Meng F, Yu Z, Zhang D, Chen S, Guan H, Zhou R . Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell. 2021; 81(20):4147-4164.e7. DOI: 10.1016/j.molcel.2021.07.040. View

3.
Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P . Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res. 2007; 67(2):520-7. DOI: 10.1158/0008-5472.CAN-06-1608. View

4.
Hennigan R, Foster L, Chaiken M, Mani T, Gomes M, Herr A . Fluorescence resonance energy transfer analysis of merlin conformational changes. Mol Cell Biol. 2009; 30(1):54-67. PMC: 2798298. DOI: 10.1128/MCB.00248-09. View

5.
Gronholm M, Sainio M, Zhao F, Heiska L, Vaheri A, Carpen O . Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin. J Cell Sci. 1999; 112 ( Pt 6):895-904. DOI: 10.1242/jcs.112.6.895. View